Glycovax-002 is under clinical development by Glycovax Pharma and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Fenretinide is under clinical development by Laurent Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Generation Beta is anyone born between 2025 and 2039. They are projected to make up roughly 16 per cent of the world’s population by 2035.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...